SCHEMBL12132772

SCHEMBL12132772

ClC[C@@H]1COC(CCl)(c2ccc(Cl)cc2)O1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.35
THRB P10828 1/20 0.35
HSP90AA1 P07900 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAOA P21397 2/20 0.33
MAOB P27338 2/20 0.33
PTGS2 P35354 1/20 0.33
KDM1A O60341 1/20 0.33
SLC6A4 P31645 3/20 0.32
SLC6A3 Q01959 3/20 0.32
CHRNA1 P02708 2/20 0.32
CHRNG P07510 2/20 0.32
CHRNB1 P11230 2/20 0.32
CHRNB2 P17787 2/20 0.32
SLC6A2 P23975 2/20 0.32
CHRNB4 P30926 2/20 0.32
CHRNA3 P32297 2/20 0.32
CHRNA4 P43681 2/20 0.32
CHRND Q07001 2/20 0.32
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12132837 1.00 CYP3A4 (0.35) CYP3A4THRBHSP90AA1NPSR1MAOA
SCHEMBL1349974 1.00 CYP3A4 (0.35) CYP3A4THRBHSP90AA1NPSR1MAOA
SCHEMBL12132847 0.87 HSP90AA1 (0.45) HSP90AA1NPSR1MAOAMAOBSLC6A3
SCHEMBL12132797 0.87 HSP90AA1 (0.45) HSP90AA1NPSR1MAOAMAOBSLC6A3
SCHEMBL12132765 0.87 MAOA (0.35) CYP3A4THRBHSP90AA1NPSR1MAOA
SCHEMBL12132778 0.87 HSP90AA1 (0.33) HSP90AA1NPSR1MAOAMAOBSLC6A3
SCHEMBL1352083 0.87 MAOA (0.35) CYP3A4THRBHSP90AA1NPSR1MAOA
SCHEMBL12132846 0.87 HSP90AA1 (0.45) HSP90AA1NPSR1MAOAMAOBSLC6A3
SCHEMBL12132845 0.87 GRIN1 (0.37)
SCHEMBL12132844 0.87 GRIN1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110288315-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND DAISO CO., LTD. (JP) 2011-11-24 US disclosed
US-20110288315-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND DAISO CO., LTD. (JP) 2011-11-24 US disclosed
EP-2325178-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND DAISO CO., LTD. (JP) 2011-05-25 EP disclosed
WO-2010013510-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND ダイソー株式会社 (JP) 2010-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110288315-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE COMPOUND CYP51A1, KMO, TALDO1 CYP3A4 14/4885THRB 4004/4885HSP90AA1 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.